Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Novel molecular mechanism of macrophage polarization in sepsis

Award Number: R21AI151943
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/13/2020
PERIOD OF PERFORMANCE END DATE: 01/31/2023

Group Awards By:

View Award Description

Novel molecular mechanism of macrophage polarization in sepsis - Project summary Novel mechanism for regulating macrophage polarization in sepsis Sepsis is a challenging clinical problem, and the pathogenesis is not clear. Macrophages (MΦs) are dynamically modified by septic insult, with different cell subsets arising during early and late stages of sepsis development. MΦs are heterogeneous in tissues; they polarize into M1 (pro-inflammatory) and M2 (anti-inflammation) upon environmental stimuli. How MΦ polarization occurs in response to sepsis is largely unknown. Our long-term goal is to elucidate the molecular mechanism underlying MΦ polarization in sepsis pathogenesis. Here, we propose to test the original idea that Sirt6 drives MΦ polarization in septic lung. Sirt6 is a histone deacetylase family member that has been shown to promote TNF-α production and maintain MΦ glucose homeostasis. Thus, Sirt6 modification of histone marks may be involved in the epigenetic regulation of MΦ polarization. Moreover, a septic insult alters the MΦ microRNA (miRNA) profile, important mediators of post-transcriptional gene expression, which are increasingly recognized as being critical to myeloid cell development. Whether miRNA regulates Sirt6 in MΦ polarization in response to septic insult is unknown. Our central and innovative hypothesis is that sepsis-associated changes in miRNA regulate the expression of Sirt6, which in turn targets histone marks to drive expression of genes involved in MΦ polarization. In preliminary studies, we found that (1) sepsis induces Sirt6 and phenotypic changes in pulmonary MΦs; (2) Sirt6 is differentially expressed in BMDM M1 and M2 cells and determine their cytokine phenotypes; (3) A typical miRNA regulates Sirt6 expression in MΦ polarization; and (4) an acetylated histone mark is differentially expressed in M1 and M2 in an opposite pattern to that of Sirt6. Based on these evidences, we proposed to determine whether Sirt6 controls pulmonary MΦ polarization in sepsis and if yes, determine the underlying mechanism. In Aim 1, we will set up a myeloid-specific Sirt6 knockout mice strain to define how deletion of Sirt6 affects pulmonary MΦ phenotypes during early and late sepsis. We will also determine the association of Sirt6 with pulmonary MΦs in septic lung by flow cytometry sorting and Western blot analysis. In Aim 2, we will explore the roles of miRNA and histone acetylation in Sirt6 regulation of MΦ polarization. We expect that the proposed research will identify Sirt6 as a regulator of MΦ polarization and characterize a miRNA-Sirt6-H3K27ac axis as a novel mechanism that drives pulmonary MΦ activation in sepsis pathogenesis. Our findings may lead to the identification of novel targets for the development of new therapies that address the pathophysiology of sepsis.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2021	ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO	225 E CHICAGO AVE	CHICAGO	IL	60611	COOK	USA	Allergy and Infectious Diseases Research	000	2	1/5/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $191,250 )
2021	2021	ANN & ROBERT H. LURIE CHILDREN'S HOSPITAL OF CHICAGO	225 E CHICAGO AVE	CHICAGO	IL	60611	COOK	USA	Allergy and Infectious Diseases Research	000	2	1/14/2021	NON-COMPETING CONTINUATION	$191,250
														Subtotal = $191,250

Issue Date FY: 2020 ( Subtotal = $229,500 )
2020	2020	ANN & ROBERT H. LURIE CHILDREN'S HOSPITAL OF CHICAGO	225 E CHICAGO AVE	CHICAGO	IL	60611	COOK	USA	Allergy and Infectious Diseases Research	000	1	2/13/2020	NEW	$229,500
														Subtotal = $229,500

Grand Total All Awards = $420,750

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Novel molecular mechanism of macrophage polarization in sepsis

Award Number: R21AI151943

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/13/2020

PERIOD OF PERFORMANCE END DATE: 01/31/2023

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer